Depletion of the natural killer cell population in the peritoneum by AK-5 tumor cells overexpressing Fas-ligand: A mechanism of immune evasion

被引:26
作者
Khar, A [1 ]
Varalakshmi, C [1 ]
Pardhasaradhi, BVV [1 ]
Ali, AM [1 ]
Kumari, AL [1 ]
机构
[1] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India
关键词
Fas-L; AK-5; tumor; immune escape; NK cell function;
D O I
10.1006/cimm.1998.1367
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
AK-5 tumor hills 100% hosts when injected ip and only 20-30% of animals die when the tumor cells are transplanted sc. Seventy percent of animals regress the subcutaneous tumor and exhibit total immunity against subsequent challenges of AK-5 cells by either route. Initially the 100% killing in ip-injected animals was attributed to the rapid growth of the tumor cells in the peritoneum thereby not giving enough time for the host immune system to mount an antitumor response. In the present report we have demonstrated overexpression of Fas-L by day 3 and day 4 ascitic tumor cells which depletes the peritoneum of Fas(+) lymphocytes. In addition the effector cells from the ascites are ineffective in inducing cytotoxicity against tumor cells in vitro. However, splenocytes from animals bearing ip tumors possessed cytotoxicity against YAC-I as web as AK-5 cells. We have also shown the presence of soluble Fas-L in the ascitic fluid, which induced DNA fragmentation in Fas(+) Jurkat cells. Fas-L present in the tumor cells is able to induce apoptosis in activated lymphocytes and Jurkat cells, suggesting retention of its biological function. These studies implicate Fas-L in the depletion of the effector cell number and inhibition of their functional activity. They also suggest differential regulation of Fas-L expression by the tumor cells depending upon the site of transplantation. (C) 1998 Academic Press.
引用
收藏
页码:85 / 91
页数:7
相关论文
共 27 条
  • [1] ABREUMARTIN MT, 1995, J IMMUNOL, V155, P4147
  • [2] BRIGHT JJ, 1995, IMMUNOLOGY, V85, P638
  • [3] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [4] DIFFERENTIAL EXPRESSION OF APO-1 ON HUMAN THYMOCYTES - IMPLICATIONS FOR NEGATIVE SELECTION
    DEBATIN, KM
    SUSS, D
    KRAMMER, PH
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (03) : 753 - 758
  • [5] Fas-ligand: Privilege and peril
    Green, DR
    Ware, CF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) : 5986 - 5990
  • [6] FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE
    GRIFFITH, TS
    BRUNNER, T
    FLETCHER, SM
    GREEN, DR
    FERGUSON, TA
    [J]. SCIENCE, 1995, 270 (5239) : 1189 - 1192
  • [7] The role of FasL-induced apoptosis in immune privilege
    Griffith, TS
    Ferguson, TA
    [J]. IMMUNOLOGY TODAY, 1997, 18 (05): : 240 - 244
  • [8] SHEDDING OF HUMAN TUMOR-ASSOCIATED ANTIGENS INVITRO AND INVIVO
    HERLYN, M
    RODECK, U
    KOPROWSKI, H
    [J]. ADVANCES IN CANCER RESEARCH, 1987, 49 : 189 - 221
  • [9] Hunt JS, 1997, J IMMUNOL, V158, P4122
  • [10] OPTIMIZING THE SOLID-PHASE IMMUNOFILTRATION ASSAY - A RAPID ALTERNATIVE TO IMMUNOASSAYS
    IJSSELMUIDEN, OE
    HERBRINK, P
    MEDDENS, MJM
    TANK, B
    STOLZ, E
    VANEIJK, RVW
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 119 (01) : 35 - 43